Benzinga's Small Cap Movers for Monday December 17, 2012
Below are highlights from Benzinga's daily coverage of small cap securities making big moves:
Shares of GenVec (NASDAQ: GNVC), the Gaithersburg, MD biopharmaceutical company, rose almost 30% Monday on 69 times average volume.
GenVec announced Monday that data were presented on its HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination, which is taking place in Ottawa, Ontario from December 13 to December 18, 2012. The company disclosed that a single administration of its genetic vaccine was effective against HSV2 in two industry-accepted HSV disease models.
Specifically, immunization was shown to reduce viral shedding, and the recurrence and severity of lesions.
GenVec's HSV vaccine candidate generated effective immune responses in animal models; and is composed of two novel antigens, as well as a proprietary, non-human adenoviral vector.
GenVec closed at $1.70 on Monday.
Shares of Uranium Resources (NASDAQ: URRE), the Lewisville, TX Uranium exploration and mining company, rose 25% Monday on 5 times average volume.
Uranium Resources announced Monday that it has filed a proxy statement to seek shareholder approval of a reverse stock split. The Company also announced the closing of $5 million in bridge financing with Resource Capital Fund V L.P. and the Company's plan to undertake a shareholder rights offering in 2013.
Uranium Resources closed at $0.41 on Monday.
OCZ Technology Group
Shares of OCZ Technology Group (NASDAQ: OCZ), the San Jose, CA provider of high-performance solid-state drives for computing devices and systems, rose 15% Monday on higher than average volume.
OCZ Technology Group announced Monday that it has initiated a beta test program for its Linux Acceleration Software development and invites its enterprise SSD customers to participate. The new OCZ LXL Software is a fast caching storage solution for OCZ's portfolio of enterprise SSDs and designed specifically for Linux-based physical and virtual environments.
OCZ Technology Group closed at $1.90 on Monday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.